USE OF INTESTINAL BACTERIA IN THE TREATMENT OF METABOLIC DISORDERS - Banco de Patentes
Back USE OF INTESTINAL BACTERIA IN THE TREATMENT OF METABOLIC DISORDERS
USE OF INTESTINAL BACTERIA IN THE TREATMENT OF METABOLIC DISORDERS

CSIC and UV have discovered a new intestinal bacterium (Holdemanella sp.) involved in the control of metabolism and homeostasis, with promising applications for the treatment of eating disorders such as obesity, and metabolism associated diseases like type 2 diabetes and cardiovascular diseases.
INDUSTRIAL PROPERTY RIGHTS
PCT application filed.
FURTHER INFORMATION
Sectoral environment: Health Promotion and Efficient Health
Entity: Consejo Superior de Investigaciones Científicas (CSIC)
Entity: Consejo Superior de Investigaciones Científicas (CSIC)
CONTACT:
Instituto de Agroquímica y Tecnología de Alimentos
Yolanda Sanz Herranz
Email: yolsanz@iata.csic.es
Catedrático José Beltran, 2
46980 Paterna